Beihai Gofar Marine Biological Industry Co Ltd (600538) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-10.30 Million ≈ $-1.51 Million USD) by net assets (CN¥785.32 Million ≈ $114.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Beihai Gofar Marine Biological Industry liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Beihai Gofar Marine Biological Industry Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Beihai Gofar Marine Biological Industry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beihai Gofar Marine Biological Industry Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Man Infraconstruction Limited
NSE:MANINFRA
|
0.007x |
|
Xinjiang Winka Times Dept
SHG:603101
|
0.106x |
|
Amex Exploration Inc
V:AMX
|
-0.002x |
|
Hangzhou Juheshun New Material Co Ltd
SHG:605166
|
-0.008x |
|
Vastned Retail Belgium
BR:VASTB
|
0.014x |
|
PCL Technologies Inc
TW:4977
|
0.004x |
|
USI Corp
TW:1304
|
0.000x |
|
Imricor Medical Systems Inc
AU:IMR
|
-0.853x |
Annual Cash Flow Conversion Efficiency for Beihai Gofar Marine Biological Industry Co Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Beihai Gofar Marine Biological Industry Co Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see 600538 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥700.78 Million ≈ $102.55 Million |
CN¥-13.40 Million ≈ $-1.96 Million |
-0.019x | -872.57% |
| 2024-12-31 | CN¥787.39 Million ≈ $115.22 Million |
CN¥1.95 Million ≈ $285.10K |
0.002x | +112.11% |
| 2023-12-31 | CN¥879.30 Million ≈ $128.67 Million |
CN¥-17.97 Million ≈ $-2.63 Million |
-0.020x | -24.61% |
| 2022-12-31 | CN¥959.98 Million ≈ $140.48 Million |
CN¥-15.74 Million ≈ $-2.30 Million |
-0.016x | -138.70% |
| 2021-12-31 | CN¥922.61 Million ≈ $135.01 Million |
CN¥-6.34 Million ≈ $-927.46K |
-0.007x | -121.79% |
| 2020-12-31 | CN¥851.56 Million ≈ $124.61 Million |
CN¥26.84 Million ≈ $3.93 Million |
0.032x | +473.92% |
| 2019-12-31 | CN¥645.61 Million ≈ $94.47 Million |
CN¥-5.44 Million ≈ $-796.48K |
-0.008x | +84.07% |
| 2018-12-31 | CN¥637.56 Million ≈ $93.30 Million |
CN¥-33.75 Million ≈ $-4.94 Million |
-0.053x | -196.61% |
| 2017-12-31 | CN¥659.18 Million ≈ $96.46 Million |
CN¥36.12 Million ≈ $5.29 Million |
0.055x | +302.99% |
| 2016-12-31 | CN¥688.79 Million ≈ $100.79 Million |
CN¥-18.59 Million ≈ $-2.72 Million |
-0.027x | -204.70% |
| 2015-12-31 | CN¥737.84 Million ≈ $107.97 Million |
CN¥-6.54 Million ≈ $-956.52K |
-0.009x | +84.25% |
| 2014-12-31 | CN¥729.59 Million ≈ $106.76 Million |
CN¥-41.05 Million ≈ $-6.01 Million |
-0.056x | -26.81% |
| 2013-12-31 | CN¥111.53 Million ≈ $16.32 Million |
CN¥-4.95 Million ≈ $-724.11K |
-0.044x | +83.13% |
| 2012-12-31 | CN¥91.60 Million ≈ $13.40 Million |
CN¥-24.09 Million ≈ $-3.52 Million |
-0.263x | -215.90% |
| 2011-12-31 | CN¥191.61 Million ≈ $28.04 Million |
CN¥-15.95 Million ≈ $-2.33 Million |
-0.083x | -27.56% |
| 2010-12-31 | CN¥225.47 Million ≈ $32.99 Million |
CN¥-14.71 Million ≈ $-2.15 Million |
-0.065x | -514.62% |
| 2009-12-31 | CN¥207.37 Million ≈ $30.34 Million |
CN¥-2.20 Million ≈ $-322.18K |
-0.011x | -119.93% |
| 2008-12-31 | CN¥325.43 Million ≈ $47.62 Million |
CN¥17.34 Million ≈ $2.54 Million |
0.053x | -38.36% |
| 2007-12-31 | CN¥492.89 Million ≈ $72.13 Million |
CN¥42.60 Million ≈ $6.23 Million |
0.086x | -51.04% |
| 2006-12-31 | CN¥529.39 Million ≈ $77.47 Million |
CN¥93.45 Million ≈ $13.67 Million |
0.177x | +3215.25% |
| 2005-12-31 | CN¥551.30 Million ≈ $80.67 Million |
CN¥2.94 Million ≈ $429.53K |
0.005x | -53.20% |
| 2004-12-31 | CN¥522.14 Million ≈ $76.41 Million |
CN¥5.94 Million ≈ $869.21K |
0.011x | +1364.46% |
| 2003-12-31 | CN¥478.86 Million ≈ $70.07 Million |
CN¥-430.83K ≈ $-63.04K |
-0.001x | -100.78% |
| 2002-12-31 | CN¥147.53 Million ≈ $21.59 Million |
CN¥17.01 Million ≈ $2.49 Million |
0.115x | -35.72% |
| 2001-12-31 | CN¥130.15 Million ≈ $19.05 Million |
CN¥23.35 Million ≈ $3.42 Million |
0.179x | -- |
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly… Read more